JPMorgan Chase & Co. Reiterates Underweight Rating for Amlin (AML)
Amlin (LON:AML)‘s stock had its “underweight” rating reiterated by research analysts at JPMorgan Chase & Co. in a report released on Wednesday, AR Network reports. They currently have a GBX 400 ($6.25) price target on the stock. JPMorgan Chase & Co.’s price target indicates a potential upside of 4.71% from the company’s current price.
Several other analysts have also recently commented on the stock. Analysts at Bank of America Corp. reiterated an “underperform” rating on shares of Amlin (LON:AML) in a research note to investors on Monday. Separately, analysts at Credit Suisse reiterated an “underperform” rating on shares of Amlin (LON:AML) in a research note to investors on Wednesday, August 21st. They now have a GBX 386 ($6.04) price target on the stock. Finally, analysts at Oriel Securities Ltd reiterated a “hold” rating on shares of Amlin (LON:AML) in a research note to investors on Tuesday, August 20th. They now have a GBX 400 ($6.25) price target on the stock.
Three analysts have rated the stock with a sell rating, nine have issued a hold rating and five have issued a buy rating to the company’s stock. Amlin currently has a consensus rating of “Hold” and a consensus target price of GBX 431.83 ($6.75).
Amlin (LON:AML) opened at 382.10 on Wednesday. Amlin has a 1-year low of GBX 361.20 and a 1-year high of GBX 444.80. The stock has a 50-day moving average of GBX 395.4 and a 200-day moving average of GBX 410.5. The company’s market cap is £1.907 billion.
Amlin plc is engaged in non-life insurance and reinsurance underwriting in the Lloyd’s market, Bermuda and Continental Europe.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.